Audit of Self-Administered Injectable Adrenaline Prescription in Primary Care

    
 
Adrenaline Audit Introduction
Adrenaline Audit Specification
How to do the Audit
View/enter data
Registered User Page
Guideline Audit Home

Introduction

This audit on Self-Administered Injectable Adrenaline is designed to assist health professionals to evaluate and optimise their care of patients diagnosed with anaphylaxis to ensure that the patients are appropriately investigated, treated and taught how to recognise and manage severe allergic reactions.

Patients prescribed injectable adrenaline for self-treatment of severe allergic reactions need to be able to use their medication in situations involving life-threatening emergencies. Therefore it is essential that they (or a responsible adult caring for a child) should be able to administer the medication.

This audit has been developed with advice from Professor Aziz Sheikh, Edinburgh, Professor Chris Corrigan of Guys and St Thomas Hospital and Mr David Reading, of the United Kingdom Anaphylaxis Campaign (http://www.anaphylaxis.org.uk/). It has been kindly sponsored by an unrestricted educational grant from Lincoln Medical.

It is the second in a series by Dr Mark L Levy (www.consultmarklevy.com), produced as a service to colleagues and their patients who will benefit from participation in a medical audit.

Click here for information on how to participate.

Click here for the audit specification.

Who is this audit for?

General practitioners and practice nurses caring for patients who have severe allergies, perhaps a past history of an anaphylactic reaction, and who have been prescribed injectable adrenaline. (eg in the United Kingdom an EpiPen or an Anapen)

Definition of Anaphylaxis:
(See http://www.resus.org.uk/pages/reaction.pdf)
Anaphylaxis is likely when all of the following 3 criteria are met:
  1. Sudden onset and rapid progression of symptoms
  2. Life-threatening Airway and/or Breathing and/or Circulation problems
  3. Skin and/or mucosal changes (flushing, urticaria, angioedema)

This audit will provide clinicians with information regarding their prescribing patterns for patients requiring self administered injectable adrenaline, and will enable immediate online comparison with other clinicians. This will provide information for discussion and implementation of any changes in practice that might be needed.

 

 


Website developed by www.danzigdesigns.com